Evidence map›Paper›PMID 35126728›Full record

ArticleOncology letters2022

Jiayin Yuan, Takako Kihara, Neinei Kimura, Takashi Yamasaki, Makoto Yoshida, Koji Isozaki, Akihiko Ito, Seiichi Hirota

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Pathology oncology research : POR · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jiayin YuanDepartment of Surgical Pathology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.
Takako KiharaDepartment of Surgical Pathology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.
Neinei KimuraDepartment of Surgical Pathology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.
Takashi YamasakiDepartment of Surgical Pathology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.
Makoto YoshidaDepartment of Surgical Pathology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.
Koji IsozakiDepartment of Surgical Pathology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.
Akihiko ItoDepartment of Pathology, Faculty of Medicine, Kindai University, Osaka-Sayama, Osaka 589-8511, Japan.
Seiichi HirotaDepartment of Surgical Pathology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.
Hyogo Medical University · JPKindai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the human gastrointestinal tract. Small intestinal GISTs appear to be associated with poorer prognosis and higher metastasis rate than gastric GISTs of the same size and mitotic index. Recently, we reported that cell adhesion molecule 1 (

Indexed as

adhesion to vascular endothelial cellscell adhesion molecule 1gastrointestinal stromal tumorproliferationtransendothelial migration

Identifiers

PMID35126728
PMCPMC8805184
OpenAlexW4210886551

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.